Cargando…
Systemic Therapy for Elderly Patients with Gastrointestinal Cancer
The majority of patients with gastrointestinal cancers are over the age of 65. This age group comprises the minority of the patients enrolled in clinical trials, and it is unknown whether older patients achieve similar results as younger patients in terms of survival benefit and tolerability. In add...
Autores principales: | Hubbard, Joleen M., Grothey, Axel, Sargent, Daniel J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095025/ https://www.ncbi.nlm.nih.gov/pubmed/21603244 http://dx.doi.org/10.4137/CMO.S6983 |
Ejemplares similares
-
Adjuvant Therapy for Colon Cancer: Learning from the Past to Inform the Future
por: Sargent, Daniel, et al.
Publicado: (2010) -
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2015) -
Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer
por: Carr, Ryan M., et al.
Publicado: (2021) -
Systemic therapy of non-colorectal gastrointestinal malignancies in the elderly
por: Desai, Avni M., et al.
Publicado: (2015) -
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
por: Xie, Hao, et al.
Publicado: (2020)